byū/met’ ə/nīd Brand Names: Bumex® Generic Available Common Dosage Forms: Tablets: 0.5 mg, 1 mg and 2 mg Injection: 0.25 mg/mL FDA Indications/Dosages: Treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease (including the nephrotic syndrome): Oral: 0.5 mg to 2 mg daily given in one to two doses.…
byū/met’ ə/nīd Brand Names: Bumex® Generic Available Common Dosage Forms: Tablets: 0.5 mg, 1 mg and 2 mg Injection: 0.25 mg/mL FDA Indications/Dosages: Treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease (including the nephrotic syndrome): Oral: 0.5 mg to 2 mg daily given in one to two doses.…
bri/mo’ ni/dēn Brand Names: Alphagan® P Generic Available Common Dosage Forms: Ophthalmic Solution: 0.1% brimonidine tartrate with Purite® 0.005% as a preservative. 0.15% brimonidine tartrate with Purite® 0.005% as a preservative. FDA Indications/Dosages: For the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension: The recommended dose is one drop in…
bī/möt’ ə/prōst Brand Names: Lumigan®, Latisse® Generic Available Common Dosage Forms: Ophthalmic solution: 0.01% and 0.03% Ophthalmic solution (Latisse): 0.03%* *Latisse is indicated to increase eyelash growth including length, thickness and darkness and is not covered on this card. FDA Indications/Dosages: For the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular…
